Retrospective study of radiologically confirmed hospital-acquired venous thromboembolic disease

被引:2
|
作者
Carrim, ZI
Ruckley, CV
Boyd, J
Sutherland, M
Murchison, JT
机构
[1] Univ Edinburgh, Royal Infirm Edinburgh, Dept Surg, Edinburgh EH3 9YW, Midlothian, Scotland
[2] Royal Infirm Edinburgh NHS Trust, Dept Clin Effectiveness, Edinburgh, Midlothian, Scotland
[3] Royal Infirm Edinburgh NHS Trust, Dept Clin Radiol, Edinburgh, Midlothian, Scotland
关键词
venous thromboembolism; prophylaxis; pulmonary embolism; deep vein thrombosis;
D O I
10.1258/026835505774964919
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To study hospital-acquired venous thromboembolic disease (HAVTED) and the relationship between its incidence and compliance with thromboprophylaxis protocols. Methods: For the past eight years, specialty-specific protocols for VTE prophylaxis have been in operation throughout this hospital. Patients developing radiologically proven VTE either as inpatients or within 12 weeks of discharge were identified from a register. Patients were categorized according to risk as per the Scottish Intercollegiate Guidelines Network (SIGN) guidelines. The use of pharmacological prophylaxis for VTE was recorded. Results: Over a period of 24 months, 98 patients had radiologically proven HAVTED. Of 44 categorized as high risk, 17 (39%) had received prophylaxis. Corresponding figures for 50 at medium risk and four at low risk were 16 (32%) and three (75%), respectively. The overall incidence of HAVTED averaged two per 1000 inpatient discharges varying between 0.2 in General Medicine and 6.6 in Trauma Orthopaedics. The mean additional cost of treating a case of HAVTED was estimated at 3,000. pound Conclusion: Audit of radiological investigations of VTE showed that 18% of all cases were hospital acquired. A hospital policy of thromboprophylaxis may reduce but does not eliminate HAVTED. A substantial proportion of patients with HAVTED had not received prophylaxis. The possibility of a further reduction in incidence of HAVTED with potential saving in morbidity, mortality and cost is highlighted. The implementation and efficacy of thromboprophylaxis protocols should be monitored.
引用
收藏
页码:196 / 199
页数:4
相关论文
共 50 条
  • [41] Utilizing large language models for detecting hospital-acquired conditions: an empirical study on pulmonary embolism
    Cheligeer, Cheligeer
    Southern, Danielle A.
    Yan, Jun
    Wu, Guosong
    Pan, Jie
    Lee, Seungwon
    Martin, Elliot A.
    Jafarpour, Hamed
    Eastwood, Cathy A.
    Zeng, Yong
    Quan, Hude
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2025, 32 (05) : 876 - 884
  • [42] Hospital acquired venous thromboembolism in children with sickle cell disease
    Agarwal, Shreya
    Foster, Kayla L.
    Anum, Shaniqua J.
    Shapiro, Mary C.
    Han, HyoJeong
    Scheurer, Michael E.
    Airewele, Gladstone
    Sartain, Sarah E.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (07) : 459 - 469
  • [43] Model-Guided Decision-Making for Thromboprophylaxis and Hospital-Acquired Thromboembolic Events Among Hospitalized Children and Adolescents
    Walker, Shannon C.
    French, Benjamin
    Moore, Ryan P.
    Domenico, Henry J.
    Wanderer, Jonathan P.
    Mixon, Amanda S.
    Creech, C. Buddy
    Byrne, Daniel W.
    Wheeler, Allison P.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2337789
  • [44] Prophylaxis guidelines as assessed retrospectively on a cohort of hospital-acquired venous thrombosis medical patients without thromboprophylaxis
    Ng, H. J.
    Leong, Y. H.
    Siow, L. K.
    Yeang, S. H.
    Wong, S. Y.
    Lee, L. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 83 - 83
  • [45] Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates
    Mahan, Charles E.
    Borrego, Matthew E.
    Woersching, Alex L.
    Federici, Robert
    Downey, Ross
    Tiongson, Jay
    Bieniarz, Mark C.
    Cavanaugh, Brendan J.
    Spyropoulos, Alex C.
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) : 291 - 302
  • [46] Predictors of recurrence of venous thromboembolic disease after discontinuing of anticoagulation: a prospective cohort study
    Lourdes Posadas-Martinez, Maria
    Torres Gomez, Felipe
    Mezzarobba, Daniela
    Schutz, Natalia
    Ruberto, Jesica
    Dovasio, Fernanda
    Elba Martinuzzo, Marta
    Javier Vazquez, Fernando
    Bernaldo de Quiros, Fernan
    Giunta, Diego
    MEDWAVE, 2021, 21 (11):
  • [47] Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
    Connelly-Frost, Alexandra
    Shantakumar, Sumitra
    Kobayashi, Monica G.
    Li, Haojie
    Li, Li
    BMC CANCER, 2013, 13
  • [48] Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect
    Santo Signorelli, Salvatore
    Conti, Gea Oliveri
    Carpinteri, Giuseppe
    Lumera, Giovanni
    Fiore, Maria
    Dattilo, Giuseppe
    Gaudio, Agostino
    Ferrante, Margherita
    ENVIRONMENTAL RESEARCH, 2021, 197
  • [49] Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
    Alexandra Connelly-Frost
    Sumitra Shantakumar
    Monica G Kobayashi
    Haojie Li
    Li Li
    BMC Cancer, 13
  • [50] Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study
    Yang, Huitang
    Zhang, Tonghe
    Li, Zhaoyang
    Cai, Yandong
    Jiang, Zhan
    Fan, Guoju
    Wang, Kaiqiang
    Chen, Bo
    Zhang, Hongwei
    Hu, Hailong
    Li, Yankui
    BMC CANCER, 2025, 25 (01)